Resource Summary

Clinical Question:
Does CVT-002 (COLD FX®) reduce the chance of upper respiratory tract infections (URTI) or influenza?

Bottom-line:
Much of the COLD FX® research is limited by trial design and reporting/analysis issues. The evidence is neither consistent nor convincing enough to recommend COLD FX® to prevent viral URTI in seniors or adults.


*** Original Documents can be found and downloaded using the link provided below ***

https://www.acfp.ca/tools-for-practice/

Publication Date: 2015-5-26
Last Updated on PCR: 2017-03-31 15:24:51